M ultidrug resistance (MDR) systems that respond to and inactivate cytotoxic compounds with diverse structures and targets are found in most forms of life (1, 2) . These mechanisms are usually active against a large variety of chemically and structurally diverse compounds while still being selective for certain substance classes, such as heterocyclic, hydrophobic compounds with specific hydrogen bond acceptor motifs (3) . Structural information, which would provide a rationale for this polyspecific recognition is scarce, as few transporter structures with bound substrates have been solved with limited resolution (4, 5) .
The most well-known MDR mechanism is active transport by efflux pumps, like ABC (6) (7) (8) (9) (10) (11) , RND, SMR, and MFS (4) efflux pumps, which confer resistance to numerous anticancer (5) and antimicrobial drugs (12) . However, cytoplasmic proteins can also sequester and thereby inactivate toxic compounds such as bleomycin, β-lactams, and fusidic acid (13) (14) (15) (16) or drugs such as cisplatinum, melphalan, and chlorambucil (17) . The expression of MDR transporters is often regulated by transcription factors, which sense the presence of the substrates by direct interaction and have a similar spectrum of multidrug recognition (18) . This overlap of recognition specificity by regulatory and effector gene partners also favors the evolution of MDR systems. High-resolution structures of such transcription factors as complexes with various substrates (19) (20) (21) (22) reveal structural motifs, which are assumed to be similar to those found in MDR transporters (4, 10) . Multidrug recognition is often achieved in a large hydrophobic pocket with multiple binding possibilities, but two-site binding is also observed, whereby specific recognition of a part of the ligand occurs in a rigid slot connected to a larger vestibule that accommodates the variable ligand remainder (10) .
The bacterial transcriptional activator TipA (thiostrepton induced protein A) of Streptomyces lividans (23) exhibits a novel multidrug recognition mechanism, in which drug binding induces folding of a larger, intrinsically unstructured part of the protein (24) . By this mechanism, TipA recognizes a variety of thiopeptide antibiotics such as thiostrepton, nosiheptide, or promothiocin A, and confers resistance via up-regulation of the tipA gene and possibly other MDR systems (23) (24) (25) . The thiopeptide antibiotics induce expression of the tipA gene as two alternate in-frame translation products: a long protein, TipAL (253 aa), and a short protein, TipAS (144 aa), which also constitutes the C-terminal part of TipAL (24, 26) . TipAL belongs to the MerR family of stress response regulators, characterized by their homologous N-terminal DNA-recognition domains; however, its mechanism of promoter activation has distinctive characteristics (27) . Their highly diverse C-terminal domains (19, 20, 28) recognize a wide variety of ligands ranging from divalent metal ions to large antibiotics (29) . The C-terminal TipAS domain of the TipA proteins recognizes thiopeptides and defines a large subfamily within the MerR proteins (24) . The tipA gene is often found in Streptomyces strains that do not produce thiopeptides, whereas thiopeptide-producing strains rather carry the thiostrepton-resistance gene tsr (30) , which provides stronger thiostrepton protection via ribosome methylation (31) . Currently, the TipAS subfamily in the Pfam database (32) includes 1,938 proteins widely distributed over many common pathogenic and environmental bacteria (Fig. S1A) . A phylogenetic tree of these bacteria reveals homologs in Firmicutes (1,321 proteins in 969 species), Actinobacteria (252 proteins in 205 species),
Significance
Multidrug recognition is an important phenomenon that is not well understood. TipA, a bacterial transcriptional regulator, constitutes a minimal multidrug resistance system against numerous thiopeptide antibiotics. We show that motions in the millisecond to microsecond time range form the basis of the TipA multidrug recognition mechanism. This may be common to many multidrug recognition systems. The discovery that the structural antibiotic motifs essential for binding to TipA and to the ribosome are identical makes the multidrug recognition mechanism of TipA a useful model for ribosomal thiopeptide binding and current antibiotic drug development.
Proteobacteria (176 proteins in 145 species), and other phyla (Chloroflexi, Bacteroidetes, Cyanobacteria, Acidobacteria, and Thermotogae).
Antibiotics belonging to the thiostrepton class react with TipAS or TipAL to form a covalent bond between a dehydroalanine residue of the antibiotic and cysteine-214 of the protein (33) . Antibiotic binding to TipAL increases the affinity to its operator site and stabilizes binding of the RNA polymerase to the ptipA promoter (27) . TipAL binds DNA as a dimer and presumably, by analogy to MerR (28, 29, 34) , might activate transcription of tipA by twisting the DNA. In S. lividans cultures induced with thiostrepton, TipAS is expressed in large molar excess (>20:1) over TipAL (26) . The sequestration of the drug by TipAS constitutes a resistance mechanism (25) , and the druginduced TipAL activation provides a feedback loop for tipA expression. Thus, TipAL/TipAS represents a minimal autoregulated MDR system (Fig. 1 ) that responds to and inactivates multiple thiopeptides. The wide distribution of TipA homologs suggests that the TipAS family provides similar MDR functions against ubiquitous, related metabolites in diverse bacterial phyla.
Thiopeptide antibiotics are sulfur-containing, highly modified macrocyclic peptides (35) that target the bacterial ribosome at the interface between the 23S rRNA and the L11 ribosomal protein (36) (37) (38) (39) . This interaction inhibits translation and also synthesis of the global gene expression regulator (p)ppGpp (40, 41) . Furthermore, thiostrepton inhibits the proteasome in eukaryotic cells (42, 43) exerting antimalarial (44, 45) and anticancer (42) (43) (44) (45) (46) (47) activities. Despite their unique mechanism of action and their high potency against pathogens such as methicillin-resistant Staphylococcus aureus and Enterococcus faecium or penicillin-resistant Streptococcus pneumonia (48), the clinical application of thiopeptides is impeded by their considerable size and low water solubility (35, (48) (49) (50) (51) . However, recent progress in thiopeptide chemical synthesis (43, 52) , biosynthesis (53, 54) , and activity screens (55) may enable the development of new thiopeptide derivatives with improved pharmaceutical properties.
A previous NMR analysis (24) has shown that apo TipAS consists of an unfolded N-terminal region of approximately 50 aa and a C-terminal, globin-like α-helical structure with a deep hydrophobic, antibiotic binding cleft [Protein Data Bank (PDB) ID code 1NY9]. Here we report the NMR solution structures and dynamics of TipAS complexes with the antibiotics promothiocin A and nosiheptide as well as a high-resolution model of the TipAS·thiostrepton complex. These data give unique insights into multidrug recognition by a complete MDR system: (i) specific recognition of a conserved antibiotic chemical motif is achieved by conserved TipAS amino acids and induces folding of the unstructured apo N terminus; and (ii) the variable part of the antibiotic is accommodated in the large, flexible hydrophobic cleft, which rigidifies upon binding. This mechanism allows promiscuous, yet specific recognition of the entire class of TipAinducing thiostrepton antibiotics. The identified recognition motif is also the major interacting part of thiostrepton and nosiheptide in complexes with the D. radiodurans ribosome (38) . Hence, the tipA multidrug resistance mechanism is directed against the same motif, which is responsible for the antibiotic inhibition of protein synthesis. This structural determinant might serve as a scaffold for the development of new antibiotics.
Results and Discussion

NMR Analysis and Structure Determination of TipAS Antibiotic
Complexes. The N-terminal region (residues M110-D164) of apo TipAS is largely unstructured and highly mobile (24) . This leads to broadening of the respective amino acid resonances and crowding in the central, random coil region of the apo 1 H- 15 N-HSQC (heteronuclear single quantum coherence) spectrum (Fig.  2) . In contrast, binding of thiostrepton (Fig. S2 ), promothiocin A (Fig. 2) , and nosiheptide ( Fig. 2) induces large changes toward a more dispersed spectrum, indicative of a transition to a folded N-terminal structure. Nevertheless, the TipAS·thiostrepton spectrum still contains many overlapping, broadened resonances resulting from conformational heterogeneity, which precluded the determination of a high-resolution structure based on the NMR data. In contrast, heterogeneity is much reduced in the promothiocin A and nosiheptide complexes, such that a full structure determination was possible. Protein C-filtered and -edited NOESY and J-correlation spectra (56) .
Despite their higher quality, structural heterogeneity is also observed in the spectra of the promothiocin A and nosiheptide TipAS complexes. In both cases, residues M110-S154 at the N terminus as well as N203 and Y205 in the loop between helices α10 and α11 that contacts the N terminus (as detailed later) show a second set of slightly shifted resonances indicative (Fig. 2 ) of a minor (30-50%) population with almost identical structure. This was confirmed by a detailed analysis of NOESY spectra. Similarly, the C-terminal region (A248-P253) of both complexes has a second conformation of ∼21% population that could be traced to the peptide bond cis-trans equilibrium of residue P253. The formation of a covalent bond between the dehydroalanine of promothiocin A and the sulfur atom of residue C214 is evident from a strong shift of the C214 13 C β resonance (26.6 to 36.2 ppm) in the TipAS·promothiocin A complex, whereas this resonance was unobservable in the TipAS·nosheptide complex as a result of conformational exchange.
Structure determinations for both complexes were carried out for their main conformations. The large number of measured structural parameters such as 74 (131) intermolecular NOEs (Fig. S3 ) and 157 (222) RDCs for the TipAS·promothiocin A (TipAS·nosiheptide) complex resulted in highly defined structures ( Fig. 3 and Table S1 ). The heavy atom coordinate rmsds are 0. of degrees of freedom as a result of the second ring. Although not detectable by chemical shifts in the TipAS·nosiheptide complex, a covalent bond between the sulfur atom of C214 and the nosiheptide dehydroalanine C β atom is evident from the distance in the calculated structures without using this bond as a restraint. This is consistent with the observation that nosiheptide and TipAS form an irreversible complex in vivo and in vitro (25) .
Antibiotics Induce a Fold That Encloses them in a Globin-Like "Sandwich."
The structures of the promothiocin A and nosiheptide complexes ( Fig. 3 ) reveal that antibiotic binding causes the flexible N terminus of the apo structure to fold into three new helices (α6-α8) and to extend helix α9 of the apo state by two additional N-terminal turns. The antibiotic sits in a deep cleft between helices α9 and α13 already present in the apo state, hereafter referred to as the apo antibiotic binding cleft, and the newly formed N-terminal helices α7 and α8 cover its opposite face, such that it is almost fully enclosed by protein. Despite the varying size of the ligand, the structures of the promothiocin A and nosiheptide complexes are very similar (1.33 Å heavy atom protein backbone rmsd). Minor differences appear in the N-terminal region, where, as a result of missing resonances from conformational exchange, helix α7 in the TipAS·promothiocin A complex is less well defined and shorter than in the complex with the larger nosiheptide. Apparently, in the latter complex, the increased antibiotic contacts stabilize α7 and extend this helix toward the N terminus (Fig. 3) .
It was previously observed that the fold of the apo TipAS structure has high similarity to the globin family of proteins [DALI server (57) z-score 4.2 to the Ascaris hemoglobin; PDB ID code 1ASH (58)] despite a low sequence identity (11%) (24) . In addition, the antibiotic is located within the TipAS fold in an analogous position as the heme in globins, and, similarly to TipAS, heme binding to apo globins induces folding of additional α-helices (59). The high fold similarity is maintained for the holo structure of TipAS (z-score 4.1 to the Ascaris hemoglobin, 9% sequence identity), which includes 50 additional Nterminal residues (Fig. S4 ). This similarity may indicate that the globin fold has emerged by convergent evolution as a motif that is especially suited for the recognition of macrocyclic structures such as heme or thiostrepton antibiotics, or that the ancestral antibiotic resistance proteins of the TipA class have recruited heme as a ligand, thereby acquiring new functions related to protection from oxygen or oxygen transport (24) . The latter hypothesis is supported by phylogenetic analyses of globins (60) that point to a bacterial origin of this protein family with horizontal gene transfer occurring from bacteria to eukaryotes at a later stage. Along these lines, it seems very likely that the evolution of an oxygen transport function accompanied the emergence of multicellular animals (61) . In contrast, the evolution of antibiotic resistance genes in antibiotic-producing bacteria seems to have taken place parallel to the evolution of the corresponding bacteria (62), i.e., much earlier.
Modeling of the Thiostrepton Complex. As the spectra of the TipAS·thiostrepton complex did not allow a structure determination, we sought to model this important complex based on the experimentally most well defined TipAS·nosiheptide structure. As a starting structure, nosiheptide was replaced by thiostrepton with coordinates from its X-ray structure (PDB ID code 1E9W) (63) . In a subsequent simulated annealing step, all intraprotein restraints of the TipAS·nosiheptide complex were retained. The position of thiostrepton was constrained by additional antibioticprotein NOEs taken from the TipAS·nosiheptide data involving L170   D168  V249  E182 A180  E210  D242  D191  R172  V175   M178   R241   A238   D230   F174   T252  T171  D127  R224  M190  N247   F225  A232  Y209  E217  K233  T226  R250  M240   R227  H251  N228   Y219  Q198   S221   G111   S186  G208   N203   G235   V220   G199   T213   G181  D185   G188 residues Thz1, Thr2, But3, and Thz4, which are conserved between nosiheptide and thiostrepton. The resulting 10 lowest-energy structures of this TipAS·thiostrepton model are included as a Dataset S1. The TipAS·thiostrepton complex (Fig. 3) has a very similar overall appearance as the promothiocin A and nosiheptide complexes, with thiostrepton sandwiched between apo helices and antibiotic-induced N-terminal helices. Also, this model structure is well defined (Table S1 ) with a very low overall energy, namely, the insertion of the larger thiostrepton into the antibiotic cavity did not cause any steric clashes. As shown earlier (25) , residue C214 of TipAS forms a covalent bond with one of the two thiostrepton dehydroalanine residues, Dha15 or Dha16. The calculated structure of TipAS·thiostrepton is consistent only with a bond to Dha15, and repeating the structure calculations with this bond included did not lead to perturbations. In contrast, calculations with a bond between Dha16 and C214 resulted in strongly violated restraints. Possibly, such a bond may form in vitro in a subpopulation, causing the heterogeneous appearance of the TipAS·thiostrepton NMR spectra (Fig. S2) .
Multidrug Recognition Occurs in a Large Hydrophobic Cavity Covered by a Ligand-Induced Lid. All three antibiotic complexes show a very similar overall organization of the binding interface and orientation of the antibiotics. Despite its small size, promothiocin A forms numerous hydrophobic contacts with the protein. One half of its ring structure (residues Ala8, Thz5, Ala10, Oxb6) inserts into the apo antibiotic binding cleft and makes contacts with the side chains of residues I200, H204, Y205, L215, M218, Y219, F225, and I229 (Fig. 4 and Fig. S5 ). Only part of the cleft is filled by the antibiotic, whereas a volume of 372 Å 3 remains as an internal void presumably filled by water molecules. The other half of the promothiocin A ring (Pyr7, Thz1, Val2, Gyn3, Oxa4) contacts residues F126, Y131, V135, W139, and Y145 located on the N-terminal α-helices α7 and α8 and their adjacent linkers. Apparently, these contacts induce the folding of the N terminus. The Nterminal structure is then further stabilized by hydrophobic clusters between helices α6, α9, and α8 formed by residues I112, L114, K119, V122, F123, W160, I163, T152, and Y155.
The larger antibiotic nosiheptide binds with its first ring A in almost the same way to TipAS as the single ring of the smaller promothiocin A (Fig. 4) . One half of this ring again inserts into the apo antibiotic binding cleft, whereas the other side contacts the N-terminal helices and apparently causes their folding. In contrast, the second ring B is directed into the internal void that had been left in the promothiocin A complex, thereby reducing its volume to 85 Å 3 . As a result, additional hydrophobic contacts are established between nosiheptide residue Ind9 and protein residues I112, F123, and W160 (Fig. S5) . Compared with the promothiocin A complex, ring A is shifted slightly toward helix α7. This shift leads to stronger contacts with residues P128, Y131, and R138 and stabilizes helix α7, as evident from the suppression of the conformational exchange broadening.
Although thiostrepton has an even larger volume, the model structure of its complex reveals that thiostrepton binds in a very similar way to TipAS as the other two antibiotics. Its first ring A is also positioned between the apo cavity and the N-terminal (Fig. S6) were fitted by the LipariSzabo model-free approach (84) . Exchange contributions R ex from micro-to millisecond flexibility and subnanosecond order parameters S 2 are shown for apo TipAS (green), TipAS·promothiocin A (cyan), and TipAS·nosiheptide (blue). Residues, which are in van der Waals contact with the ligand, are highlighted in yellow on the R ex data panel. (Top) Secondary structures of apo TipAS and the two complexes. Solid cylinders represent α-helices. structure, whereas its large ring B still fits very well into the internal void without perturbing the antibiotic-induced fold of the N terminus or other parts of the structure (Fig. 4 and Fig. S5 ). In all three complexes, the protein tightly encloses the antibiotic such that only 4-7% of its surface area remains accessible to solvent (Table S1 ).
The Drug Recognition Interface Is Dynamic. To understand the dynamical aspects of the multidrug recognition, the TipAS apo and holo forms were analyzed by 15 N relaxation experiments ( Minor exceptions are the micro-to millisecond exchange in helix α7 of the promothiocin A complex, which rendered many resonances invisible in this region, as well as reduced nanosecond order (S 2 ) in loops between helices, e.g., α6/α7, α8/α9, α10/α11, and α12/α13.
In contrast, the dynamical behavior of the apo form is much more varied. In its unfolded N-terminal region (G111-Q164), a large number of 1 It is remarkable that the rotational correlation time of apo TipAS is larger than that of the complexes despite its approximately 1 kDa smaller mass. Presumably, the slower diffusion of the apo form is caused by the viscous drag from the large unstructured N terminus. Significant exchange contributions R ex are observed for a number of residues in the folded C-terminal part of apo TipAS (Fig. 5) . These mobile residues of the apo form are located in a region different from the observed heterogeneity in the N-and C-terminal parts of antibiotic complexes. Notably, most of these residues line the antibiotic binding pocket and make van der Waals contacts with the antibiotic in the complex, where this exchange is abrogated. This is particularly pronounced for residues H196 to R202 of helix α10, and helices α11 and α12. Thus, the backbone of the binding pocket is flexible on the micro-to millisecond time scale before antibiotic binding, but becomes locked when the pocket is filled in the complex. The motions in the microsecond to millisecond time scale of residues located in the cleft of apo TipAS favor conformational selection (64, 65) over an induced fit mechanism for the antibiotic recognition. Accordingly, helices α11 and α12 of the TipAS·antibiotic complexes exhibit the largest displacements upon ligand binding (Fig. 3) .
Identifying the Specific Thiopeptide Recognition Motif. The transcription of the tipA gene in S. lividans is induced by many cyclic thiopeptides of highly variable primary structure and size ( Fig. 6 and Table S2 ) (23, 25, 66, 67) . Many of these inducers contain dehydroalanine moieties that may form a covalent bond with residue C214. However, the presence of dehydroalanine is not a necessary condition for tipA induction (25) . Thus, recognition clearly involves an additional chemical motif. The following comparison of the promothiocin A, nosiheptide, and thiostrepton complex structures with the chemical structures of all known tipA inducers reveals this common thiopeptide chemical motif recognized by the TipA proteins.
One half of the antibiotic ring A is more strongly conserved among the tipA inducers than the rest of their chemical structure (Fig. 6 ). This half, ranging from a thia-or oxazole (position 6, promothiocin A numbering) over a pyridyl or piperidyl (position 7), a thiazole (position 1), to a thia-or oxazole ring (position 4), has almost identical contacts and orientation in all three TipAS complexes (Fig. 4) . It is positioned at the top of the antibiotic cleft of apo TipAS and oriented toward the newly formed Nterminal helices. The thia-/oxazole, pyridyl/piperidyl, and thiazole rings in positions 6, 7, and 1 are recognized from one side by hydrophobic and stacking interactions, respectively, with the side chains of L215 and Y205 at the opening of the cleft (Figs. 4 and  7) . From the other side, this triple ring system is covered by the aromatic rings of the N-terminal residues W139 and Y145. Similarly, the thia-or oxazole ring at position 4 stacks onto the aromatic ring of F225 at the top of the cleft, whereas its upper face makes extensive contacts with the side chains of the Nterminal residues F126, Y131, and V135. Apparently, the contacts to these specific recognition residues induce the fold of the N terminus into a defined helical bundle structure on top of the apo antibiotic binding cleft. The relevance of the (mostly aromatic) recognition residues Y131, W139, Y145, L215, and F225 is further corroborated by their high conservation across the currently available 1938 homologous TipAS sequences (Fig.  S1B) , making it plausible that very similar antibiotic recognition and drug-induced folding mechanisms occur in a large variety of bacteria.
Without exception, all known tipA inducers (Fig. 6 ) contain the specific antibiotic motif recognized in the three TipAS complex structures: a thia-/oxazole(I)-pyridyl/piperidyl(II)-thiazole(III) triple ring system and a fourth thia-or oxazole ring (IV), which is separated from thiazole(III) by a dipeptide linker of seven bonds (Fig. 6, magenta) . We have searched all thiopeptides described in the literature (35) and the THIOBASE database (68) for a match of this motif. Besides the known 15 chemical scaffolds of tipA inducers, this analysis identified 13 additional thiopeptides as putative tipA inducers (Table S2 ). In contrast, five thiopeptides in this data set did not match the recognition motif. Three of these (amythiamicin, cyclothiazomycin, and GE 2270A) are known not to induce tipA, whereas the two others (thiomuracin, GE37468) are putative new noninducers.
TipA Recognizes the Same Thiopeptide Motif That Binds to the Ribosome and Inhibits Translation. Most thiopeptide antibiotics inhibit protein synthesis by targeting the GTPase-associated center of the ribosome at the site of contact between the ribosomal protein L11 and the 23S rRNA (69) . Whereas NMR studies had previously given insights into dynamics and domain orientations of thiostrepton complexes with L11 and 23S rRNA fragments (70, 71) , crystallographic structures of complexes of the entire 50S subunit of the D. radiodurans ribosome with thiostrepton or nosiheptide are now available (38) . Thiostrepton and nosiheptide (Fig. 8) bind in a very similar mode into a hydrophobic cleft between L11 and helices H43 and H44 of the 23S rRNA such that the side of ring A with the identified TipA recognition motif inserts deepest into this pocket. Thiazole rings III and IV make intimate contacts with the bases of A1106 and A1078, respectively, whereas thiazole and pyridyl/piperidyl ring I+II contact the L11 residue P25 (D. radiodurans numbering). In particular, bases A1106 and A1078 have been identified as strong determinants of thiostrepton binding by single point mutations (72) and the fact that 2′O-methylation of A1078 renders thiostrepton-producing streptomycetes self-resistant (31, 72) . In contrast, the nonconserved part of the chemical structure of thiostrepton and nosiheptide does not form contacts, as it is directed toward the open bulk solvent. Therefore, the specific recognition of TipA for thiopeptide antibiotics is directed against the same chemical motif that is recognized by the ribosome and inhibits protein biosynthesis. In both cases, the variable part of the antibiotic is accommodated by a nonselective void. The specific TipA recognition of the same antibiotic motif, which is harmful to bacteria, provides further strong evidence that indeed the TipA family of proteins constitute a resistance mechanism against thiopeptide antibiotics. (Fig. 6) . The hydrophobic cavity of apo TipAS is shown in green. Ring A of the thiopeptide (promothiocin A shown) inserts into the cavity and makes specific contacts from Oxb6(I), Pyr7(II), Thz1(III), and Oxa4(IV) to residues L215, Y205, F225 in the cavity. This induces the folding of the unstructured N terminus (blue) into a helical structure on top of the antibiotic, which recognizes the thiopeptide motif (aromatic rings I-IV) via specific contacts from residues F126, Y131, V135, W139, and Y145.
The Constitutive Elements of the Thiopeptide-Specific TipA Multidrug Recognition. Our study identifies the main elements of the promiscuous, yet specific, recognition of thiopeptide antibiotics by TipA. (i) The variable part of the antibiotics inserts into a void that is large enough to accommodate their differing sizes. The walls of this void are lined by hydrophobic residues, which are flexible in the absence of antibiotic and lock into a single or very few conformations upon ligand binding, thereby optimizing the contacts. (ii) The specific recognition of the thiopeptide motif is achieved from one side by residues at the entrance of this cavity and from the other side by residues of the flexible N terminus that locks on top of the cavity upon ligand binding. This N terminus is not entirely flexible in the apo form. The considerable exchange broadening in this region, which varies according to the sequence position of the holo form helices, indicates that minor populations of these helices connected by flexible linkers may already be present without antibiotic. These prestructured elements would reduce the entropic cost of the ligand-induced rigidification of the N terminus and help in the specific recognition of the thiopeptide motif. (iii) The binding pose induced by the specific recognition also orients the dehydroalanine-bearing tail, which is present in many but not all TipA inducers, such that it can form a covalent bond with residue C214.
The TipA thiopeptide recognition mechanism contains some of the features previously identified in multidrug recognition of MDR gene regulators (10), i.e., a large hydrophobic pocket with unspecific, multiple contact possibilities on a flexible surface and second site binding for specific recognition. However, the TipA recognition mechanism also contains the additional element of folding upon binding (73) of a flexible, yet not completely unstructured, part of the molecule. Remarkably, this feature is part of the specific recognition. Thus, the recognition is a mixture of induced fit for the unspecific part of the antibiotic and conformational selection for its specific part. As the N-terminal part of TipAS connects to the DNA binding domain in the transcriptional regulator TipAL, its folding upon binding very likely also constitutes the mechanical signal by which antibiotic binding induces expression of tipA and possibly of other MDR genes (24, 25) . The conformational selection of the unfolded N terminus to a well-defined, almost identical structure in all three TipAS complexes would then position the DNA binding domain in an appropriate way to bind promoter DNA with higher affinity and recruit RNA polymerase to the complex (27) . This specific positioning of the DNA binding domain and the subsequent induction of transcription needs to emerge from the specific thiopeptide recognition motif. It could not be achieved reliably by an induced-fit accommodation of the nonconserved antibiotic part, as the latter would lead to variable N-terminal helix orientations.
Conclusion
In summary, we have identified the mechanism of multidrug recognition in the autonomously regulated thiopeptide MDR system TipA. The polyspecific recognition is based on a delicate mixture of binding the variable part of the antibiotic in a flexible hydrophobic internal cavity combined with specific binding of a conserved thiopeptide TipA inducer motif that leads to folding of the TipAS N terminus by conformational selection. The high sequence homology within the TipA subfamily of MerR proteins indicates that this mechanism may be common to numerous bacteria. The identified thiopeptide TipA inducer motif is also the site of the antibiotic that forms the essential contact to the ribosome to suppress protein translation. This structural motif may be a valuable lead in designing new thiopeptide antibiotics against clinically relevant pathogens. Moreover, the observed congruence of chemical motifs responsible for antibiotic function and antibiotic resistance may be a general principle to identify new antibiotic leads also in other MDR systems. By using a concept of linguistics, we might use the knowledge of diachrony in synchrony (74) , the evolutionary wisdom of bacterial resistance mechanisms in drug development today. 
Materials and Methods
Protein Preparation and NMR Samples. TipAS and its complexes with promothiocin A or nosiheptide were prepared as described previously (24, 25 NMR Spectroscopy, Resonance Assignments, and Structure Calculations. NMR spectra were recorded on TipAS complexes at 298 K on Bruker DRX 600 and DRX 800 NMR spectrometers equipped with TXI and TCI probe heads, respectively. Standard NMR experiments similar to the ones described previously (75) were performed for protein assignment, structure information, and assessment of backbone dynamics by 15 N relaxation. Antibiotic proton resonances were assigned by 2D NOESY and HOHAHA (homonuclear HartmannHahn) spectra filtered against 1 H bound to 13 C or 15 N (56). NMR data were processed by using the NMRPipe suite of programs (76) , and spectra were displayed and analyzed with the programs SPARKY (77) and PIPP (78) . Analysis of relaxation data were carried out with the program Modelfree 4.15 (79) .
Structure calculations were performed with the program XPLOR-NIH (80) by using consecutive simulated annealing protocols (81): calculations started from an extended strand with the antibiotic bound to the protein via the covalent bond between the dehydroalanine of the antibiotic tail and C214 using intraprotein restraints only. After the protein and the ligand had condensed into a folded structure, the intermolecular covalent bond was switched off, and the structure calculation continued with all intra-and intermolecular experimental restraints. The results showed that the dehydroalanine was in bonding distance to C214, and the bond was then reintroduced as a restraint in a final step. Parameterization of the antibiotics was created by using the Cambridge Structural Database (82) . A total of 100 structures per complex were calculated, and the 10 lowest-energy structures, chemical shifts, other NMR data, and details of experiments were deposited in the respective databanks (TipAS·promothiocin A, PDB ID code 2MBZ, BMRB accession no. 19421; TipAS·nosiheptide, PDB ID code 2MC0, BMRB accession no. 19422). Statistics for the complex structures are given in Table  S1 . Structure figures were generated using PyMOL (83) .
